Advertisement

Annals of Hematology

, Volume 68, Issue 5, pp 215–223 | Cite as

Inadequate erythropoietin response to anemia: definition and clinical relevance

  • G. Barosi
Review Article

Summary

The development of a specific and sensitive immunoassay for the measurement of serum erythropoietin (s-Epo) allows to improve our understanding of the model of in vivo regulation of erythropoiesis. In most anemias, circulating hemoglobin level determines Epo production which in turn stimulates erythropoietic activity. The disruption of the expected feedback mechanism of Epo production leads to an inadequately low s-Epo. The definition of inadequate Epo response to anemia relies on the documentation of a downregulated dependence of s-Epo on Hb with respect to the same dependence in patients with a physiologically regulated erythropoiesis. Literature reports a wide range of so called adequate s-Epo response to anemia and a number of criteria for judging on the adequateness of s-Epo at a certain degree of anemia. The O/P (observed/predicted) ratio allows categorization of each individual patient. The clinical syndromes in which an inadequate Epo response has been reported are numerous and the mechanisms of defective Epo production are different. A number of evidences clearly point to a relation between responsiveness to r-Hu-Epo and inadequate Epo response. This inequivocabily confirms the role inadequate Epo response plays in the pathogenesis of anemia.

Key words

Erythropoietin Erythropoiesis Inadequate erythropoietin production 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Abedi MR, Backman L, Borstrom L, Lindback B, Ringden O (1990) Markedly increased serum erythropoietin levels following conditioning for allogeneic bone marrow transplantation. Bone Marrow Transpl 6:121–126Google Scholar
  2. 2.
    Abels RI (1992) Recombinant human erythropoietin in the treatment of the anaemia of cancer. Acta Haematol 87 [Suppl 1]:4-llGoogle Scholar
  3. 3.
    Adamson JW, Schuster JW, Allen S, Haley NR (1992) Effectiveness of recombinant human erythropoietin therapy in myelodysplastic syndromes. Acta Haematol 87 [Suppl 1]:20–24Google Scholar
  4. 4.
    Ariad S, Clifford D, Penfold G, MacPhail AP, Bezwoda WR (1992) Erythropoietin response in anaemic patients with multiple myeloma and other lymphoid malignancies infiltrating the bone marrow. Eur J Haematol 49:59–62Google Scholar
  5. 5.
    Baer AN, Dessypris EN, Goldwasser E, Krantz SB (1987) Blunted erythropoietin response to anemia in rheumatoid arthritis. Br J Haematol 66:559–564Google Scholar
  6. 6.
    Baer AN, Dessypris EN, Krantz SB (1990) The pathogenesis of anemia in rheumatoid arthritis: a clinical and laboratory analysis. Semin Arthr Rheum 19:209–223Google Scholar
  7. 7.
    Barosi G, Cazzola M, Stefanelli M, Berzuini C, Quaglini S (1985) Classification of anaemia by means of ferrokinetic parameters. Br J Haematol 61:357–370Google Scholar
  8. 8.
    Barosi G (1993) Control of erythropoietin production in man. Haematologica (Pavia) 78:77–79Google Scholar
  9. 9.
    Barosi G, Liberato NL, Guarnone R (1993) Serum erythropoietin in patients with myelofibrosis with myeloid metaplasia. Br J Haematol 83:365–369Google Scholar
  10. 10.
    Bechensteen AG, Lappin TRJ, Marsden J, Muggleston D, Cotes PM (1993) Unreliability in immunoassays of erythropoietin: anomalous estimates with an assay kit. Br J Haematol 83:663–664Google Scholar
  11. 11.
    Beguin Y, Lipscei G, Thoumsin H, Fillet G (1991) Blunted erythropoietin production and decreased erythropoiesis in early pregnancy. Blood 78:89–93Google Scholar
  12. 12.
    Beguin Y, Yerna M, Loo M, Weber M, Fillet G (1992) Erythropoiesis in multiple myeloma: defective red cell production due to inappropriate erythropoietin production. Br J Haematol 82:648–653Google Scholar
  13. 13.
    Beguin Y, Clemons GK, Pootrakul P, Fillet G (1993) Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin. Blood 81:1067–1076Google Scholar
  14. 14.
    Bergamaschi G, Recalde HH, Ponchio L, Rosti V, Cazzola M (1993) Erythrophagocytosis increases the expression of erythroid potentiating activity mRNA in human monocytemacrophages. Exp Hematol 21:70–73Google Scholar
  15. 15.
    Bessho M, Jinnai I, Matsuda A, Saito M, Hirashima K (1990) Improvement of anemia by recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemia. Int J Cell Cloning 8:445–458Google Scholar
  16. 16.
    Birgegard G, Wide L, Simonsson B (1989) Marked erythropoietin increase before fall in Hb after treatment with cytostatic drugs suggests mechanism other than anaemia for stimulation. Br J Haematol 72:462–466Google Scholar
  17. 17.
    Blanchard KL, Schneider TJ, Acquaviva A, Goldberg WA (1992) Studies on the mechanism of tumor necrosis factor alpha inhibition of hypoxia-induced erythropoietin production. Blood 80 [Suppl 1]:151aGoogle Scholar
  18. 18.
    Bosi A, Vannucchi AM, Grossi A, Guidi S, Saccardi R, Rafanelli D, Longo G, Rossi Ferrini P (1991) Inadequate erythropoietin production in allogeneic bone marrow transplant patients. Haematologica (Pavia) 76:280–284Google Scholar
  19. 19.
    Bowen DT, Jacobs A, Cotes MP, Lewis TC (1990) Serum erythropoietin and erythropoiesis in patients with myelodysplastic syndromes. Eur J Haematol 44:30–32Google Scholar
  20. 20.
    Bowen D, Culligan D, Jacobs A (1991) The treatment of anaemia in myelodysplastic syndromes with recombinant human erythropoietin. Br J Haematol 77:419–423Google Scholar
  21. 21.
    Boyd KH, Lappin TRJ (1991) Erythropoietin deficiency in the anemia of chronic disorders. J Intern Med 229:49–55Google Scholar
  22. 22.
    Boyer SH, Bishop TR, Rogers OC, Noyes AN, Frelin LP, Hobbs S (1992) Roles of erythropoietin, insulin-like growth factor 1, and unidentified serum factors in promoting maturation of purified murine erythroid colony-forming units. Blood 80:2503–2512Google Scholar
  23. 23.
    Bray GL, Taylor B, O'Donnell R (1992) Comparison of the erythropoietin response in children with aplastic anemia, transient erythroblastopenia, and iron deficiency. J Pediatr 120:528–532Google Scholar
  24. 24.
    Camacho J, Poveda F, Zamorano AF, Valencia ME, Vazquez JJ, Arnalich F (1992) Serum erythropoietin levels in anaemic patients with advanced human immunodeficiency virus infection. Br J Haematol 82:608–614Google Scholar
  25. 25.
    Carpenter MA, Kendall RG, O'Brien AE, Chapman C, Sebastian JP, Belfield PW, Norfolk DR (1992) Reduced erythropoietin response to anaemia in elderly patients with normocytic anaemia. Eur J Haematol 49:119–121Google Scholar
  26. 26.
    Casadevall N, Belanger C, Goy A, Varet B, Lang J, Poisson D (1992) High-dose recombinant human erythropoietin administered intravenously for the treatment of anaemia in myelodysplastic syndromes. Acta Haematol 87 [Suppl 1]:25–27Google Scholar
  27. 27.
    Cazzola M, Beguin Y (1992) New tools for clinical evaluation of erythron function in man (annotation). Br J Haematol 80:278–284Google Scholar
  28. 28.
    Cazzola M, Ponchio L, Beguin Y, Rosti V, Bergamaschi G, Liberato NL, Fregoni V, Nalli G, Barosi G, Ascari E (1992) Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase-I/II clinical trial. Blood 79:29–37Google Scholar
  29. 29.
    Chandra M, Clemons GK, McVicar MI (1988) Relation of serum erythropoietin levels to renal excretory function: evidence for lowered set point for erythropoietin production in chronic renal failure. J Pediatr 113:1015–1021Google Scholar
  30. 30.
    Christensen RD, Hunter DD, Goodell H, Rothstein G (1992) Evaluation of the mechanism causing anemia in infants with bronchopulmonary dysplasia. J Pediatr 120:593–598Google Scholar
  31. 31.
    Cotes PM, Tam RC, Reed P, Hellebostad M (1989) An immunological cross-reactant of erythropoietin in serum which may invalidate EPO radioimmunoassay. Br J Haematol 73:265–268Google Scholar
  32. 32.
    Deacon R, Hellebostad M, Gaines Das RE, Milne A, Rowley M, Cotes PM (1993) Invalidity from nonparallelism in a radio-immunoassay for erythropoietin accounted for by human serum antibodies to rabbit IgG. Exp Hematol 21:1680–1685Google Scholar
  33. 33.
    De Klerk G, Rosengarten PGJ, Vet RJW, Goudsmit R (1981) Serum erythropoietin (ESF) titers in anemia. Blood 58:1164–1170Google Scholar
  34. 34.
    Erslev AJ, Wilson J, Caro J (1987) Erythropoietin titers in anemic, nonuremic patients. J Lab Clin Med 109:429–433Google Scholar
  35. 35.
    Erslev AJ (1991) Erythropoietin. N Engl J Med 324:1339–1344Google Scholar
  36. 36.
    Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW (1987) Correction of the anemia of end-stage renal disease with recombinant human erythropoietin: results of a phase-I and -II clinical trial. N Engl J Med 316:73–78Google Scholar
  37. 37.
    Faquin WC, Schneider TJ, Goldberg MA (1992) Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 79:1987–1992Google Scholar
  38. 38.
    Feldman L, Frazier JG, Sytkowski AJ (1992) B-lymphocytederived burst-promoting activity is a pleiotropic erythroid colony-stimulating factor, E-CSF. Exp Hematol 20:1223–1228Google Scholar
  39. 39.
    Fischl M, Galpin JE, Levine JD, Groopman JE, Henry DH, Kennedy P, Miles S, Robbins W, Starrett B, Zalusky R, Abels RI, Tsai HC, Rudnick SA (1990) Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med 322:1488–1493Google Scholar
  40. 40.
    Gaines Das RE, Milne A, Rowley M, Smith EC, Cotes PM (1992) Serum immunoreactive erythropoietin in patients with idiopathic aplastic and Fanconi's anaemias. Br J Haematol 82:601–607Google Scholar
  41. 41.
    Gamucci T, Thorel MF, Frasca AM, Giannarell D, Calabresi F (1993) Erythropoietin for the prevention of anaemia in neoplastic patients treated with cisplatin. Br J Cancer 29A [Suppl 2]:S13-S14Google Scholar
  42. 42.
    Goch J, Birgegard G, Wilkstrom B, Tufveson G, Danielson BG (1992) Serum erythropoietin levels in the immediate kidney-posttransplant period. Nephron 60:30–34Google Scholar
  43. 43.
    Gogu SR, Malter JS, Agrawal KC (1992) Zidovudine-induced blockade of the expression and function of the erythropoietin receptor. Biochem Pharmacol 44:1009–1012Google Scholar
  44. 44.
    Goldwasser E, Beru N, Hermine O (1991) Some aspects of the regulation of erythropoietin gene expression. Semin Hematol 28:28–34Google Scholar
  45. 45.
    Grace RJ, Kendall RG, Chapman C, Hartley AE, Barnard DL, Norfolk DR (1991) Changes in serum erythropoietin levels during allogeneic bone marrow transplantation. Eur J Haematol 47:81–85Google Scholar
  46. 46.
    Hellstrom E, Birgegard G, Lockner D, Helmers C, Ost A, Wide L (1991) Treatment of myelodysplastic syndromes with recombinant human erythropoietin. Eur J Haematol 47:355–360Google Scholar
  47. 47.
    Henry DH, Beall GN, Benson CA, Carey J, Cone LA, Eron LJ, Fiala M, Fischl MA, Gabin SJ, Gottlieb MS, Galpin JE, Groopman JE, Hooton TM, Jemsek JG, Levine RL, Miles SA, Rinehart JJ, Rios A, Robbins WJ, Ruckdeschel JC, Smith JA, Spruance SL, Starrett B, Toney J, Zalusky R, Abels RI, Bryant EC, Larholt KM, Sampson AR, Rudnick SA (1992) Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Ann Intern Med 117:739–748Google Scholar
  48. 48.
    Hirashima K, Bessho M, Susaki K, Miyazawa K, Nagashima M (1989) Improvement of anemia by intravenous injections of recombinant erythropoietin in patients with myelodysplastic syndromes and aplastic anemia. Exp Hematol 17:657Google Scholar
  49. 49.
    Hochberg MC, Arnold CM, Hogans BB, Spivak JL (1988) Serum immunoreactive erythropoietin in rheumatoid arthritis: impaired response to anemia. Arthritis Rheum 31:1318–1321Google Scholar
  50. 50.
    Hoeldtke RD, Steeten DHP (1993) Treatment of orthostatic hypotension with erythropoietin. N Engl J Med 329:611–615Google Scholar
  51. 51.
    Ireland RM, Atkinson IC, Concannon A, Dodds A, Downs K, Biggs JC (1990) Serum erythropoietin changes in autologous and allogeneic bone marrow transplant patients. Br J Haematol 76:128–134Google Scholar
  52. 52.
    Jelkman W, Pagel H, Wolff M, Fandrey J (1991) Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. Life Sci 50:301Google Scholar
  53. 53.
    Koury ST, Koury MJ, Mondurant MC, Caro J, Grabar SJ (1989) Quantitation of erythropoietin-producing cells in kidney of mice by in situ hybridization: correlation with hematocrit, renal erythropoietin mRNA, and serum erythropoietin concentration. Blood 74:645–651Google Scholar
  54. 54.
    Kurzrock R, Talpaz M, Estey E, O'Brien S, Estrov Z, Gutterman JU (1991) Erythropoietin treatment in patients with myelodysplastic syndrome and anemia. Leukemia 5:985–990Google Scholar
  55. 55.
    Lapinsky SE, Baynes RD, Schulz EJ, Macphail AP, Mendelow B, Lewis D, Bothwell TH (1992) Anaemia, iron-related measurements and erythropoietin levels in untreated patients with active leprosy. J Intern Med 232:273–278Google Scholar
  56. 56.
    Lin FK, Suggs S, Lin CH, Bravne JK, Smalling R, Egrie JC, Chen KK, Fox GM, Martin F, Stabinsky Z, Badrawi SM, Lai P-H, Goldwasser E (1985) Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci USA 82:7580–7584Google Scholar
  57. 57.
    Locatelli F, Pedrazzoli P, Barosi G, Zecca M, Porta F, Liberate NL, Gambarana D, Nespoli L, Cazzola M (1992) Recombinant human erythropoietin is effective in correcting erythropoietin-deficient anaemia after allogeneic bone marrow transplantation. Br J Haematol 80:545–549Google Scholar
  58. 58.
    Ludwig H, Fritz E, Kotzmann H, Hocker P, Gisslinger H, Barnas U (1990) Erythropoietin treatment of anemia associated with multiple myeloma. N Engl J Med 322:1693–1699Google Scholar
  59. 59.
    Ludwig H, Leitgeb C, Fritz E, Krainer M, Kuhrer I, Kornek G, Sagaster P, Weissmann A (1993) Erythropoietin treatment of chronic anaemia of cancer. Eur J Cancer 29A [Suppl 2]:S8-S12Google Scholar
  60. 60.
    Mandujano JF, Barrios NJ, Kiernan MP, Beckerman RC, Fisher JW, Mather FJ (1992) Oxygen content and erythropoietin levels in anemic cystic fibrosis patients. Blood 80 [Suppl 1]:279aGoogle Scholar
  61. 61.
    McGonigle RJS, Wallin JD, Shadduck RK, Fisher JW (1984) Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency. Kidney Intern 25:437–444Google Scholar
  62. 62.
    Means RJ, Olsen NJ, Krantz SB, Graber SE (1989) Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: clinical and in vitro studies. Arthritis Rheum 32:638–642Google Scholar
  63. 63.
    Merchav S, Nielsen OJ, Rosenbaun H, Sharon R, Brenner B, Tatarsky I, Scigalla P, Wieczorek L (1990) In vitro studies of erythropoietin-dependent regulation of erythropoiesis in myelodysplastic syndromes. Leukemia 4:771–774Google Scholar
  64. 64.
    Miller CB, Jones RJ, Piantadosi S, Abeloff MD, Spivak JL (1990) Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med 322:1689–1692Google Scholar
  65. 65.
    Miller CB, Jones RJ, Zahurak ML, Piantadosi S, Burns WH, Santos GW, Spivak JL (1992) Impaired erythropoietin response to anemia after bone marrow transplantation. Blood 80:2677–2682Google Scholar
  66. 66.
    Miller CB, Platanias LC, Mills SR, Zahurak ML, Ratain MJ, Ettinger DS, Jones RJ (1992) Phase I–II trial of erythropoietin in the treatment of cisplatin-associated anemia. J Natl Cancer Inst 84:98–103Google Scholar
  67. 67.
    Mitjavilla M, Le Couedic JP, Casadevall N, Navarro S, Villeval JL, Vainchenker W (1991) Autocrine stimulation by erythropoietin and autonomous growth of human erythroid leukemia cells in vitro. J Clin Invest 8:789Google Scholar
  68. 68.
    Negrin RS, Stein R, Vardiman J, Doherty K, Cornwell J, Krantz S, Greenberg PL (1993) Treatment of the anemia of myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor in combination with erythropoietin. Blood 82:737–743Google Scholar
  69. 69.
    Nielsen OJ, Andersen LS, Ludwigsen E, Bouchlouche P, Hansen TM, Birgens H, Hansen NE (1990) Anaemia of rheumatoid arthritis: serum erythropoietin concentrations and red cell distribution width in relation to iron status. Ann Rheum Dis 49:349–353Google Scholar
  70. 70.
    Pavlovic-Kentera V, Clemons GK, Biljanovic-Paunovic L, Marisavljevic D, Lezaic V, Pokrajac M, Djukanovic L (1992) Serum erythropoietin levels in hemodialysed patients after administration of recombinant human erythropoietin. Biomed Pharmacother 46:37–43Google Scholar
  71. 71.
    Phibbs RH, Shannon KM, Mentzer WC (1992) Potential for treatment of anaemia of prematurity with recombinant human erythropoietin: preliminary results. Acta Haematol 87 [Suppl 1]:28–33Google Scholar
  72. 72.
    Pincus T, Olsen NJ, Russel IJ, Wolfe F, Harris ER, Schnitzer TJ, Boccagno JA, Krantz SB (1990) Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. Am J Med 89:161–168Google Scholar
  73. 73.
    Piroso E, Erslev AJ, Flaharty KK, Caro J (1991) Erythropoietin life span in rats with hypoplastic and hyperplastic bone marrows. Am J Hematol 36:105–110Google Scholar
  74. 74.
    Platanias LC, Miller CB, Mick R, Hart RD, Ozer H, McEvilly J-M, Jones RJ, Ratain MJ (1991) Treatment of chemotherapy-induced anemias with recombinant human erythropoietin in cancer patients. J Clin Oncol 9:2021–2026Google Scholar
  75. 75.
    Radtke HW, Claussner A, Erbes PM, Scheurmann EH, Schoeppe W, Koch KM (1979) Serum erythropoietin concentration in chronic renal failure. Relationship to degree of anaemia and excretory function. Blood 54:877–884Google Scholar
  76. 76.
    Rafanelli D, Grossi A, Longo G, Vannucchi AM, Bacci P, Rossi Ferrini P (1992) Recombinant human erythropoietin for treatment of myelodysplastic syndromes. Leukemia 6:323–327Google Scholar
  77. 77.
    Remacha AF, Rodriguez-De la Serna A, Garcia-Die F, Geli C, Diaz C, Gimferrer E (1992) Erythroid abnormalities in rheumatoid arthritis: the role of erythropoietin. J Rheumatol 19:1687–1691Google Scholar
  78. 78.
    Richman DD, Fischl MA, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Hirsch MS, Jackson GG, Durack DT, Phil D, Nusinoff-Leherman S, and the AZT Collaborative Working Group (1987) The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS-related complex. A doubleblind, placebo-controlled trial. N Engl J Med 317:192–197Google Scholar
  79. 79.
    Salvarani C, Lasagni D, Casali B, Macchioni P, Boiardi L, Rossi F, Rivasi P, Portioli I (1991) Recombinant human erythropoietin therapy in patients with rheumatoid arthritis with the anemia of chronic disease. J Rheumatol 18:1168–1171Google Scholar
  80. 80.
    Sanders M, Sorba S, Dainiak N (1993) Insulin-like growth factors stimulate erythropoiesis in serum-substituted umbilical cord blood cultures. Exp Hematol 21:25–30Google Scholar
  81. 81.
    Schapira L, Antin JH, Ransil BJ, Antman KH, Eder JP, McGarigle CJ, Goldberg MA (1990) Serum erythropoietin levels in patients receiving intensive chemotherapy and radiotherapy. Blood 76:2354–2359Google Scholar
  82. 82.
    Shepherd JD, Currie CJ, Sparling TG, Krystal G, Eaves AC (1992) Erythropoietin therapy of myelodysplastic syndromes. Blood 79:1891–1892Google Scholar
  83. 83.
    Sherwood JB, Goldwasser E, Chlcote R, Carmichael LD, Nagel RL (1986) Sickle cell anemia patients have low erythropoietin levels for their degree of anemia. Blood 67:46–49Google Scholar
  84. 84.
    Schouten HC, Vellenga E, van Rhenen DJ, de Wolf JThM, Coppens PJW, Blijham GH (1991) Recombinant human erythropoietin in patients with myelodysplastic syndromes. Leukemia 5:432–436Google Scholar
  85. 85.
    Singh A, Eckardt KU, Zimmermann A, Gotz KH, Hamann M, Ratcliffe PJ, Kurtz A, Reinhard WH (1993) Increased plasma viscosity as a reason for inappropriate erythropoietin formation. J Clin Invest 91:251–256Google Scholar
  86. 86.
    Smith DH, Guarnieri CM, Whaling SM, Vokes EE (1988) Erythropoietin response in cancer patients receiving cisplatin. Proc Am Assoc Cancer Res 29:52–56Google Scholar
  87. 87.
    Spivak JL, Barnes DC, Fuchs E, Quinn TC (1989) Serum immunoreactive erythropoietin in HIV-infected patients. JAMA 261:3104–3107Google Scholar
  88. 88.
    Stebler C, Tichelli A, Dazzi H, Gratwohl A, Nissen C, Speck B (1990) High-dose recombinant human erythropoietin for treatment of anemia in myelodysplastic syndromes and paroxysmal nocturnal hemoglobinuria: a pilot study. Exp Hematol 18:1204–1208Google Scholar
  89. 89.
    Stefanelli M, Barosi G, Cazzola M (1982) Iron kinetics. In: Cramp DG (ed) Quantitative approaches to metabolism. Wiley & Sons, Chichester, p 143Google Scholar
  90. 90.
    Stein RS, Abels RI, Krantz SB (1991) Pharmacologic doses of recombinant human erythropoietin in the treatment of myelodysplastic syndromes. Blood 78:1658–1663Google Scholar
  91. 91.
    Stenke L, Wallvik J, Celsing F, Hast R (1993) Prediction of response to treatment with human recombinant erythropoietin in myelodysplastic syndromes. Leukemia 7:1324–1327Google Scholar
  92. 92.
    Storring PL, Gaines Das RE (1992) The International Standard for Recombinant DNA-derived Erythropoietin: collaborative study of four recombinant DNA-derived erythropoietins and two highly purified human urinary erythropoietins. J Endocrinol 134:459–484Google Scholar
  93. 93.
    Takagi M, Miyamoto Y, Kosaka M, Saito S (1992) Clinical significance of serum erythropoietin levels in patients with multiple myeloma. Rinsho Ketsueki 33:1151–1157Google Scholar
  94. 94.
    Takashina N, Kondo H, Kashiwazaki S (1990) Suppressed serum erythropoietin response to anemia and the efficacy of recombinant erythropoietin in the anemia of rheumatoid arthritis. J Rheumatol 17:885–887Google Scholar
  95. 95.
    Taniguchi S, Yamasaki K, Shibuya T, Asayama R, Harada M, Niho Y (1993) Recombinant human erythropoietin for long-term persistent anemia after major ABO-incompatible bone marrow transplantation. Bone Marrow Transplant 12:423Google Scholar
  96. 96.
    Thevenod F, Radke HW, Gruetzmacher P, Vincent E, Koch KM, Schoeppe W, Fassbinder W (1983) Deficient feedback regulation of erythropoiesis in kidney transplant patients with polycythemia. Kidney Int 24:227–232Google Scholar
  97. 97.
    Urabe A, Mitani K, Yoshinaga K, Iki S, Yagisawa M, Ohbayashi Y, Takaku F (1992) Serum erythropoietin titers in hematological malignancies and related diseases. Int J Cell Cloning 10:333–337Google Scholar
  98. 98.
    Van Kamp H, Prinsze-Postema TC, Kluin PM, Den Ottolander GJ, Beverstock GC, Willemze R, Fibbe WE (1991) Effect of subcutaneously administered human recombinant erythropoietin on erythropoiesis in patients with myelodysplasia. Br J Haematol 78:488–493Google Scholar
  99. 99.
    Vannucchi AM, Grossi A, Bosi A, Rafanelli D, Guidi S, Saccardi R, Alterini R, Rossi Ferrini P (1991) Impaired erythropoietin production in mice treated with cyclosporin A. Blood 78:1615–1618Google Scholar
  100. 100.
    Ward HP, Kurnick JE, Pisarczyk MJ (1971) Serum levels of erythropoietin in anemias associated with chronic infection, malignancy and primary hemopoietic disease. J Clin Invest 50:332–335Google Scholar
  101. 101.
    Vasko SD, Burdge JJ, Ruberg RL, Verghese AS (1991) Evaluation of erythropoietin levels in the anemia of thermal injury. J Burn Care Rehabil 12:437–441Google Scholar
  102. 102.
    Vaziri ND, Kaupke CJ, Barton CH, Gonzales E (1992) Plasma concentration and urinary excretion of erythropoietin in adult nephrotic syndrome. Am J Med 92:35–40Google Scholar
  103. 103.
    Winearls CG, Oliver DO, Pippard MJ, Reid C, Downing MR, Cotes PM (1986) Effect of human erythropoietin from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet 2:1175–1178Google Scholar
  104. 104.
    Wolff M, Jelkmann W (1993) Effects of chemotherapeutic and immunosuppressive drugs on the production of erythropoietin in human hepatoma cultures. Ann Hematol 66:27–31Google Scholar
  105. 105.
    Vreugdenhil G, Wognum AW, Van Eijk HG, Swaak AJG (1990) Anemia in rheumatoid arthritis: the role of iron, vitamin B12, and folic acid deficiency, and erythropoietin. Ann Rheum Dis 49:93–98Google Scholar
  106. 106.
    Vreugdenhil G, Manger B, Nieuwenhuizen C, Feelders RA, van Eijk HG, Swaak AJG (1992) Iron stores and serum transferrin receptor levels during recombinant human erythropoietin treatment of anemia in rheumatoid arthritis. Ann Hematol 65:265–268Google Scholar
  107. 107.
    Yoshida Y, Anzai N, Kawabata H, Kohsaka Y, Okuma M (1993) Serial changes in endogenous erythropoietin levels in patients with myelodysplastic syndromes and aplastic anemia undergoing erythropoietin treatment. Ann Hematol 66:175–180Google Scholar
  108. 108.
    Zucker S, Friedman S, Lysik RM (1974) Bone marrow erythropoiesis in the anemia of infection, inflammation and malignancy. J Clin Invest 53:1132–1138Google Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • G. Barosi
    • 1
  1. 1.Clinica Medica II. Policlinico S. MatteoPaviaItaly

Personalised recommendations